Federal Reserve faces challenges amid stock market volatility and tightening credit
U.S. retail sales for February, data Fed officials will see before kicking off their two-day policy meeting on Tuesday, were ...
Morningstar3d
Sarepta's stock slammed after patient dies of liver failure. Here's what Wall Street is saying.
making it one of the most expensive therapies in the U.S. Mizuho said the selling of the stock was likely an overreaction, noting that this is the first case of acute liver failure among patients ...
INTO on MSN17d
People are gleefully cackling at Trump’s self-imposed stock market failure
We probably shouldn’t be laughing, because a plunging stock market is certainly not a fun problem to contend with, but if we ...
Trump shrugs off stock market slump, but economic warning signs loom
During Donald Trump’s first term as US president, he regularly referred to rising stock markets as evidence of the success of ...
The Upside-Down Line That Tells the Story of the Stock Market Now
When President Trump entered his first term, stocks were steadily marching upward. This time, the trajectory has inverted.
Business Insider29d
Wall Street's dangerous overconfidence
It sets you up for embarrassment, whispers, and abject failure. It's the difference ... In November and December, the stock market seemed to defy gravity. Tech stocks were untouchable.
Morningstar3d
Sarepta Therapeutics stock falls after DMM patient dies of liver failure
Sarepta Therapeutics Inc.'s stock was down 21.6% in premarket trades on Tuesday after the commercial-stage biopharmaceutical company said a patient died from liver failure after using its drug ...
Sarepta’s stock slammed after patient dies of liver failure. Here’s what Wall Street is saying.
The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.